Continuing Medical Education
Yale Cancer Center Oncology Series
This educational series held four times a year is hosted by Dr. Thomas Lynch Jr., Director of Yale Cancer Center, and Physician-in-Chief of Smilow Cancer Hospital at Yale-New Haven. Open to care providers throughout the region, the series focuses on all aspects of oncology treatment and care. The goal of the series is to provide the audience with relevant information on diagnosis, currently accepted guidelines for management, and the use of novel and multi-modal therapies for the cancer being discussed.
The Paul Calabresi Memorial Lectureship
On Tuesday, February 26, 2013, The Paul Calabresi Memorial Lectureship Grand Rounds were held. The speaker, Eric P. Winer, MD, Director, Breast Oncology Center, Dana-Farber Cancer Institute, and Professor, Department of Medicine, Harvard Medical School, spoke on "HER2+ Breast Cancer: Dramatic Advances and Ongoing Challenges." Dr. Paul Calabresi was an internationally recognized authority and pioneer on the clinical pharmacology of anticancer agents, for which he was awarded the Oscar B. Hunter Memorial Award in Therapeutics from the American Society of Clinical Pharmacology and Therapeutics in 1992.
Yale Cancer Center Grand Rounds
Yale Cancer Center Grand Rounds are held every Tuesday, September-June, at noon in the Park Street Auditorium. It is intended to provide information to help viewers better understand the current range of options for cancer treatment, prevention, screening, and supportive care. Each week is split into two 20-minute segments focused on two of the following categories: basic sciences, clinical care, or population sciences. Participation in Grand Rounds is an important component of Cancer Center membership. In order to receive CME credit for attendance, you must sign-in each week and fill out an evaluation at the completion of each series. Certificates of attendance will be distributed through the CME office. Archived videos can be found here
June 27 ASCO Review
Yale ASCO Review 2014: "Highlights of the Annual Meeting." This conference will enable participants to: Describe the current treatment options and updates in various cancer disease specialties, discuss the development and outcomes of clinical cancer research trials and assess their relevance to patient care, and assess the emerging role of novel small molecules and antibodies in oncology.